OppenheimerFunds’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,727
Closed -$215K 1875
2017
Q2
$215K Buy
+2,727
New +$215K ﹤0.01% 1796
2016
Q1
Sell
-68,840
Closed -$6.1M 1743
2015
Q4
$6.1M Buy
+68,840
New +$6.1M 0.01% 802